One in seven Canadian veterans is living with PTSD. Developing a psychedelics research program for veterans should be a public health priority.
Academic rigor, journalistic flair
Articles on MDMA-assisted psychotherapy
Displaying all articles
From July 1, authorised psychiatrists will be able to prescribe MDMA and psilocybin in some circumstances. Here’s what we’re excited and concerned about.
Receiving a cancer diagnosis and undergoing cancer treatment can be a traumatizing experience. Psychedelics like LSD, psilocybin and MDMA could help alleviate symptoms from cancer-related PTSD.
Some psychedelic drugs – paired with therapy – hold great potential for helping sufferers of PTSD, depression and other mental health disorders.
The TGA is considering a proposal to reclassify psilocybin and MDMA from their current status as prohibited substances. This would allow psychiatrists to use these drugs to treat mental illness.
The TGA is currently evaluating a proposal to legalise MDMA and psilocybin for the treatment of mental illness. But there are a few reasons Australia isn’t quite ready to take this step.
Drugs like MDMA, ketamine, LSD and psylocibin may help heal the wounds of trauma - but more research is needed.
MDMA is better known as the party psychedelic Ecstasy or Molly. Used clinically, together with psychotherapy, it reduces symptoms of post-traumatic stress disorder, and shows promise with couples.
Top contributors
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Research fellow, Swinburne University of Technology
-
Medicinal Chemist, UNSW Sydney
-
Adjunct Professor, Psychology, Faculty of Arts, Toronto Metropolitan University
-
Senior research fellow, Phoenix Australia, Department of Psychiatry, The University of Melbourne
-
PhD candidate, University of Sydney
-
Associate Professor of Comparative Effectiveness and Outcomes Research, University of Connecticut
-
Professor, School of Medicine, The University of Queensland
-
Chair of Psychiatry, The University of Melbourne
-
Psychiatrist and Clinical Associate at The Centre of Mental Health, Swinburne University of Technology
-
Professor of Psychiatry, UNSW & Black Dog Institute, UNSW Sydney
-
Senior Lecturer of Addiction, Edith Cowan University
-
Research Scientist, Queen's Health Sciences and Assistant Professor, Department of Psychiatry, Queen's University, Ontario
